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A case report describing Capnocytophaga ochracea (Bacteroides ochraceus)
septicemia in a 21-year-old male patient receiving chemotherapy for acute lym-
phocytic leukemia is presented. The unusual features of this organism are dis-
cussed together with a review of the literature.
Capnocytophaga ochracea (Bacteroides
ochraceus) is a gram-negative, nonsporeforming
capnophilic rod that produces yellow-orange
pigmentation and is a part of the normal oral
flora in healthy individuals (5). Recently, For-
lenza et al. (1) described this organism as a cause
of bacteremia in immunocompromised hosts. In
this report, we describe the presence of C. ochra-
cea septicemia in a patient with acute myeloge-
nous leukemia.
CASE REPORT
A 21-year-old black male was referred to our hos-
pital with a history of anemia, fever of unknown etiol-
ogy, and lymphadenopathy characterized by enlarged
cervical, axillary, and inguinal lymph nodes. A com-
plete blood count performed at admission revealed a
leukocyte count of 3,100/mm3, a hematocrit of 24%,
hemoglobin of 7.7 g/dl, and a platelet count of 15,000/
mmn3. Examination of a peripheral blood smear re-
vealed a predominance of blast forms. The diagnosis
of acute myelogenous leukemia was made subse-
quently by bone marrow biopsy, and the patient was
given chemotherapy which included vincristine, pred-
nisone, cytosine arabinoside, and 6-thioguanine. The
patient's disease proved refractory to four separate
courses of this treatment during his prolonged hospital
stay. Throughout his admission, the patient experi-
enced several febrile episodes which were not found to
be of an infectious etiology. At no time during his
prolonged hospital course did his leukocyte count ex-
ceed 3,500/mm3.
A blood culture taken on day 71 of the patient's
hospital stay yielded a strain of Escherichia coli that
was resistant to ampicillin, carbenicillin, and tetracy-
cline, but susceptible to cephalothin, gentamicin, and
tobramycin. The patient was treated with cefazolin
and tobramycin, and blood cultures taken on days 73
and 74 were negative. The patient remained febrile
despite antibiotic therapy. Two blood cultures were
obtained from the patient on day 77 of hospitalization.
On this day it was also noted that the patient's
oral hygiene, which had been poor at admission, had
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deteriorated, and his gums were bleeding. A rectal
abscess cultured on day 75 contained a mixture of
aerobic, facultative, and anaerobic organisms (E. coli,
diphtheroids, Streptococcus faecalis, Eubacterium
lentum, and Peptococcus sp.) and was considered to
be a possible source of the patient's fever. These
culture results led to the addition of chloramphenicol
to the patient's antibiotic treatment regimen on day
80. On day 85, the laboratory reported the recovery of
an unusual yellow-orange, gram-negative rod which
was only detected by seventh-day "blind" subculture
of the blood cultures collected on day 77.
The patient became afebrile on hospital day 90, and
all antibiotics were discontinued 2 days later. The
patient was discharged on hospital day 100. The two
blood cultures taken on day 77 grew a gram-negative
rod identified in our laboratory as C. ochracea (B.
ochraceus).
MATERIALS AND METHODS
Blood specimens were collected and subcultured by
methods previously described (4). Each blood speci-
men was thoroughly mixed and divided equally among
four 50-ml blood culture bottles. Two of these con-
tained 50 ml of Columbia broth modified by the addi-
tion of L-cysteine to a final concentration of 0.05%.
The remaining two bottles also contained the modified
medium supplemented with sucrose to a final concen-
tration of 10%. One isotonic and one hypertonic bottle
were vented after addition of the blood specimen. Ail
four culture bottles were incubated at 35°C for a
period of 7 days.
Biochemical tests employed to characterize our
strain of C. ochracea were those offered by the Mini-
tek system (BBL Microbiology Systems, Cockeysville,
Md.) using the anaerobe inoculation broth. Minitek
tests were inoculated in accordance with the manufac-
turer's recommendation and were incubated at 370C
in a glove box (Coy Manufacturing, Ann Arbor, Mich.)
with an atmosphere of 85% N2, 10% C02, and 5% H2.
Gas chromatographic analysis of fermentation prod-
ucts produced by the organism in peptone-yeast-glu-
cose broth after 48 h of anaerobic incubation were
conducted by methods previously described (2). Other
biochemical and physiological tests were those de-
scribed previously in the Virginia Polytechnic Institute
Anaerobe Laboratory Manual (2). The susceptibility
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of the bacterium to antimicrobial agents was deter-
mined by the microtiter broth dilution method of
Thornsberry and Swenson (9).
RESULTS AND DISCUSSION
The organism recovered from our patient's
blood cultures was detected by a subculture of
culture bottles after 7 days of incubation and
not ly macroscopic evidence of growth. The
bacterium grew on sheep blood agar (BBL)
when incubated at 35°C in either an anaerobic
environment or a capneic (5% C02) atmosphere.
Colonies that developed on sheep blood agar
were flat and exhibited a spreading border and
a yellow-orange pigment. Gram stains of the
colonies revealed the organism to be a thin, non-
sporeforming, gram-negative rod. The bacte-
rium produced acetic and succinic acids in pep-
tone-yeast-glucose broth and demonstrated the
biochemical reactions shown in Table 1. In-
cluded as references in Table 1 are characteris-
tics previously reported for Capnocytophaga sp.
by Socransky et al. (8). Our isolate hydrolyzed
esculin and starch and fermented glucose, lac-
tose, maltose, sucrose, and trehalose. The orga-
nism was catalase and oxidase negative and
failed to produce indole, to reduce nitrates, and
to ferment arabinose, glycerol, mannitol, and
TABLE 1. Biochemical characteristics of C.
ochracea
Cur- C. C. sputi- C. gingi-
Biochemical test rent ochra- gena' valis'
isolate cea' (27) (6) (25)
Catalase - 0 0 0
Oxidase - 0 0 0
Esculin hydroly- + 96 83 75
sis
Indole - 0 0 0




Arabinose - 4 0 0
Glucose + 100 100 100
Glycerol - NT NT NT
Lactose + 92 40 8
Maltose + 100 100 100
Mannitol - 0 0 0
Salicin - il 0 0
Sucrose + 100 100 100
Trehalose + 9 0 0
Starch hydroly- + 77 0 0
sis
Urease - 14 0 12
' Data reported by Socransky et al. (8). Numbers
within parentheses indicate the number of strains.
Results are expressed as percentage of positive strains.
NT, Not tested.
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salicin. These results agreed well with charac-
teristics described previously by Socransky et al.
(8).
Minimal inhibitory concentrations deter-
mined for our isolate were (in micrograms per
milliliter): penicillin, 2.0; carbenicillin, 1.0; ceph-
alothin, 2.0; erythromycin, 0.12; clindamycin,
0.12; chloramphenicol, 2.0; and tetracycline, 8.0.
Leadbetter and co-workers (3) proposed that
the genus and species designation C. ochracea
be used in place of B. ochraceus because the
organism requires increased carbon dioxide ten-
sion for growth (capnophilic) and exhibits glid-
ing motility as do members of the genus Cyto-
phaga. Thus the genus designation Capnocyto-
phaga describes the unique characteristics of
the organism which are not shared by members
of the genus Bacteroides.
The new genus is distinct from other genera
of gliding bacteria (Cytophaga and Flexibacter)
in that Capnocytophaga is catalase and oxidase
negative, strictly fermentative, requires carbon
dioxide, and fails to produce lactic, propionic,
and butyric acids as products of fermentation (3,
8). Three species of the new genus have been
proposed: C. ochracea, C. gingivalis, and C.
sputigena. Williams and co-workers (11) have
recently reported that seven of the eight strains
identified as Center for Disease Control group
DF-1 (10) exhibited a high degree of deoxyribo-
nucleic acid relatedness with C. ochracea, as did
four isolates previously identified as B. ochra-
ceus. Identical conclusions were obtained in a
collaborative study of 21 isolates initially char-
acterized as DF-1, B. ochraceus, or Capnocyto-
phaga sp. (6). This collaborative study, like that
of Williams and colleagues, found a high degree
of deoxyribonucleic acid relatedness among the
organisms studied and concluded that the genus
Capnocytophaga was an appropriate designa-
tion for the organism.
The spreading colonial morphology observed
by us was noted by Leadbetter and co-workers
to depend on the medium employed (3). These
investigators observed the spreading morphol-
ogy on sheep blood agar manufactured by BBL,
but not on that produced by other manufac-
turers. We also employed the medium manufac-
tured by BBL. Further investigation by Lead-
better and colleagues revealed that the spread-
ing morphology occurred on media that con-
tained at least 2% agar, but not on media with
lower agar content (3).
C. ochracea and other members of the genus
are found in the gingival sulci of humans and are
also found in periodontal pockets in patients
suffering from periodontal disease (5). The rel-
ative quantity and predominance of Capnocy-
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tophaga spp. has been reported to be increased
in patients with advanced forms of periodontal
disease (5).
Aside from our report, there are only four
other reports which document the recovery of C.
ochracea in blood cultures. No clinical history
is available for two patients whose blood cultures
yielded Capnocytophaga strains included in the
taxonomic study of Williams and co-workers
(11). Six other clinical isolates cited in the study
of Newman and co-workers (6) also lack clinical
description of the patients involved. Shurnn and
co-workers (7) described the alteration of poly-
morphonuclear leukocyte function and mor-
phology in two patients with dental disease as-
sociated with Capnocytophaga spp. One ofthese
patients had multiple myeloma and evidence of
destructive dental disease, and C. ochracea was
recovered from blood cultures obtained 3 days
apart.
Forlenza and colleagues have described six
patients who experienced 10 episodes of sepsis
caused by Capnocytophaga sp. (1). Five of the
six patients were less than 16 years of age. The
five children had either myeloblastic leukemia
or acute lymphocytic leukemia, whereas the sin-
gle adult patient had adenocarcinoma. Each of
the patients was granulocytopenic, and 7 of the
10 episodes occurred while the patient was re-
ceiving antimicrobial therapy. All patients had
ulcerations of their oral mucosa, and 8 of the 10
had bleeding gums. The patient that we describe
is similar to the six patients described by For-
lenza et al. (1) in that he was severely leuko-
penic, had bleeding gums, and developed septi-
cemia while he was receiving antimicrobial ther-
apy.
Clinical microbiologists should be aware of
Capnocytophaga sp. and its unusual cultural
and biochemical characteristics. Its association
with septicemia in the leukopenic patient and its
role in periodontal disease require further study.
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